JP2009523124A - 置換されたイミダゾリン誘導体 - Google Patents
置換されたイミダゾリン誘導体 Download PDFInfo
- Publication number
- JP2009523124A JP2009523124A JP2008546224A JP2008546224A JP2009523124A JP 2009523124 A JP2009523124 A JP 2009523124A JP 2008546224 A JP2008546224 A JP 2008546224A JP 2008546224 A JP2008546224 A JP 2008546224A JP 2009523124 A JP2009523124 A JP 2009523124A
- Authority
- JP
- Japan
- Prior art keywords
- dimethylamino
- phenyl
- dihydro
- imidazole
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000002462 imidazolines Chemical class 0.000 title claims abstract description 45
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 title claims description 22
- 239000003814 drug Substances 0.000 claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- -1 n- butyl Chemical group 0.000 claims description 87
- 239000002253 acid Substances 0.000 claims description 72
- 229910052799 carbon Inorganic materials 0.000 claims description 63
- 150000004702 methyl esters Chemical class 0.000 claims description 57
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 229910052739 hydrogen Inorganic materials 0.000 claims description 29
- 150000001299 aldehydes Chemical class 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 27
- 125000003118 aryl group Chemical group 0.000 claims description 25
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 25
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 23
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 20
- 208000002193 Pain Diseases 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 229920006395 saturated elastomer Polymers 0.000 claims description 14
- 238000011282 treatment Methods 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 125000001544 thienyl group Chemical group 0.000 claims description 10
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 9
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 208000011117 substance-related disease Diseases 0.000 claims description 8
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 239000013543 active substance Substances 0.000 claims description 6
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 208000004296 neuralgia Diseases 0.000 claims description 6
- 208000021722 neuropathic pain Diseases 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 5
- IWGVZQAPMJDBGE-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(CCC)(C(=O)OC)N=CN1CC1=CC=CC=C1 IWGVZQAPMJDBGE-UHFFFAOYSA-N 0.000 claims description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
- MIHGGZOJCPTLTI-UHFFFAOYSA-N 2-[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]acetaldehyde Chemical compound C1CC(CC=O)CCC1C(N(C)C)CCC1=CC=CC=C1 MIHGGZOJCPTLTI-UHFFFAOYSA-N 0.000 claims description 4
- SYMHWMKGOMWVFD-UHFFFAOYSA-N 2-[4-[dimethylamino(thiophen-2-yl)methyl]cyclohexyl]acetaldehyde Chemical compound C=1C=CSC=1C(N(C)C)C1CCC(CC=O)CC1 SYMHWMKGOMWVFD-UHFFFAOYSA-N 0.000 claims description 4
- 208000007848 Alcoholism Diseases 0.000 claims description 4
- 208000000094 Chronic Pain Diseases 0.000 claims description 4
- 206010012735 Diarrhoea Diseases 0.000 claims description 4
- 206010013654 Drug abuse Diseases 0.000 claims description 4
- 208000003251 Pruritus Diseases 0.000 claims description 4
- 206010046543 Urinary incontinence Diseases 0.000 claims description 4
- 206010001584 alcohol abuse Diseases 0.000 claims description 4
- 208000025746 alcohol use disease Diseases 0.000 claims description 4
- 206010013663 drug dependence Diseases 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- TVVCKGWHEFYCCM-UHFFFAOYSA-N 4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexane-1-carbaldehyde;4-[1-(dimethylamino)-3-phenylpropyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=C(F)C=CC=1C(N(C)C)C1CCC(C=O)CC1.C1CC(C=O)CCC1C(N(C)C)CCC1=CC=CC=C1 TVVCKGWHEFYCCM-UHFFFAOYSA-N 0.000 claims description 3
- DJAMXGJKOZCVJC-UHFFFAOYSA-N C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 DJAMXGJKOZCVJC-UHFFFAOYSA-N 0.000 claims description 3
- UYSWIRADPTZPLN-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCCC Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCCC UYSWIRADPTZPLN-UHFFFAOYSA-N 0.000 claims description 3
- GREDRVCBDLFPGT-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 GREDRVCBDLFPGT-UHFFFAOYSA-N 0.000 claims description 3
- OGOGQDWGOWDHPZ-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CCCC Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CCCC OGOGQDWGOWDHPZ-UHFFFAOYSA-N 0.000 claims description 3
- AEDHDWSEIWJPNN-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)C Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)C AEDHDWSEIWJPNN-UHFFFAOYSA-N 0.000 claims description 3
- JSVFNTXHMJSQAA-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)C(C)CC Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)C(C)CC JSVFNTXHMJSQAA-UHFFFAOYSA-N 0.000 claims description 3
- VWNGOHLPRNXWSI-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCC Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCC VWNGOHLPRNXWSI-UHFFFAOYSA-N 0.000 claims description 3
- WWGKSILMGXHCQJ-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 WWGKSILMGXHCQJ-UHFFFAOYSA-N 0.000 claims description 3
- ZUQIBNCWRPPZGA-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC=C(C=C1)F)N(C)C)C(C)C1=CC=CC=C1)C Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC=C(C=C1)F)N(C)C)C(C)C1=CC=CC=C1)C ZUQIBNCWRPPZGA-UHFFFAOYSA-N 0.000 claims description 3
- WGOOYOGUPPPBFZ-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC=C(C=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCC Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC=C(C=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCC WGOOYOGUPPPBFZ-UHFFFAOYSA-N 0.000 claims description 3
- RHGRPTRWSNOMSX-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CC1=CC=C(C=C1)Cl Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CC1=CC=C(C=C1)Cl RHGRPTRWSNOMSX-UHFFFAOYSA-N 0.000 claims description 3
- PLAHKKIIOPOVNT-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CCCC Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CCCC PLAHKKIIOPOVNT-UHFFFAOYSA-N 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 208000005298 acute pain Diseases 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000049 anti-anxiety effect Effects 0.000 claims description 3
- 239000002249 anxiolytic agent Substances 0.000 claims description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- CCXOXPMGQFLQHJ-UHFFFAOYSA-N methyl 3,5-dibutyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCCC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 CCXOXPMGQFLQHJ-UHFFFAOYSA-N 0.000 claims description 3
- HZSDETPZXMKBHT-UHFFFAOYSA-N methyl 3,5-dibutyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 HZSDETPZXMKBHT-UHFFFAOYSA-N 0.000 claims description 3
- OIICSYADHRIQJO-UHFFFAOYSA-N methyl 3-benzyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1C(C(=O)OC)(CC(C)C)N=CN1CC1=CC=CC=C1 OIICSYADHRIQJO-UHFFFAOYSA-N 0.000 claims description 3
- UMVZSUJJCJKGKW-UHFFFAOYSA-N methyl 3-benzyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(C(=O)OC)(CC(C)C)N=CN1CC1=CC=CC=C1 UMVZSUJJCJKGKW-UHFFFAOYSA-N 0.000 claims description 3
- VLXDQVDEQYTOED-UHFFFAOYSA-N methyl 3-benzyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(CCC(=O)OC)(C(=O)OC)N=CN1CC1=CC=CC=C1 VLXDQVDEQYTOED-UHFFFAOYSA-N 0.000 claims description 3
- KVCCTRXBOPIEFP-UHFFFAOYSA-N methyl 3-benzyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(C(=O)OC)(CSC)N=CN1CC1=CC=CC=C1 KVCCTRXBOPIEFP-UHFFFAOYSA-N 0.000 claims description 3
- SAKCACZLKYADOK-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(C(=O)OC)(CC(C)C)N=CN1CC1=CC=CC=C1 SAKCACZLKYADOK-UHFFFAOYSA-N 0.000 claims description 3
- SWKNNMIWXDGVQV-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(C(=O)OC)(CSC)N=CN1CC1=CC=CC=C1 SWKNNMIWXDGVQV-UHFFFAOYSA-N 0.000 claims description 3
- LJRRTUZRLNYNNV-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-[(4-chlorophenyl)methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(CC2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CC1=CC=C(Cl)C=C1 LJRRTUZRLNYNNV-UHFFFAOYSA-N 0.000 claims description 3
- YLUHHXLCDOZSMK-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(CCC=2C=CC=CC=2)N(C)C)CCC1CC1C(C(=O)OC)(C)N=CN1CC1=CC=CC=C1 YLUHHXLCDOZSMK-UHFFFAOYSA-N 0.000 claims description 3
- SGYIPPLJSBCLBH-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(CCC=2C=CC=CC=2)N(C)C)CCC1CC1C(CCC)(C(=O)OC)N=CN1CC1=CC=CC=C1 SGYIPPLJSBCLBH-UHFFFAOYSA-N 0.000 claims description 3
- XCBPYRVYYVUORS-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(C(=O)OC)(CCSC)N=CN1CC1=CC=CC=C1 XCBPYRVYYVUORS-UHFFFAOYSA-N 0.000 claims description 3
- KUOAGWCKWOCREZ-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1CC1=CC=CC=C1 KUOAGWCKWOCREZ-UHFFFAOYSA-N 0.000 claims description 3
- KUOAMXRUFSIQIQ-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(C(=O)OC)(C)N=CN1CC1=CC=CC=C1 KUOAMXRUFSIQIQ-UHFFFAOYSA-N 0.000 claims description 3
- SVTONLHXVSCFEC-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(C(=O)OC)(CCSC)N=CN1CC1=CC=CC=C1 SVTONLHXVSCFEC-UHFFFAOYSA-N 0.000 claims description 3
- OLGWKMSUYJRHBU-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1CC1=CC=CC=C1 OLGWKMSUYJRHBU-UHFFFAOYSA-N 0.000 claims description 3
- UFTNGKKYXRIDBG-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(C(=O)OC)(C)N=CN1CC1=CC=CC=C1 UFTNGKKYXRIDBG-UHFFFAOYSA-N 0.000 claims description 3
- WARRDGNMHZRTQP-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(CCC)(C(=O)OC)N=CN1CC1=CC=CC=C1 WARRDGNMHZRTQP-UHFFFAOYSA-N 0.000 claims description 3
- WRSJNNDEPMLFEJ-UHFFFAOYSA-N methyl 3-benzyl-5-(benzylsulfanylmethyl)-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(C2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 WRSJNNDEPMLFEJ-UHFFFAOYSA-N 0.000 claims description 3
- SOPYTKCRBDRUQB-UHFFFAOYSA-N methyl 3-benzyl-5-(benzylsulfanylmethyl)-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(C2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 SOPYTKCRBDRUQB-UHFFFAOYSA-N 0.000 claims description 3
- UGSDRXNLIQGMCN-UHFFFAOYSA-N methyl 3-benzyl-5-(benzylsulfanylmethyl)-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(CC2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 UGSDRXNLIQGMCN-UHFFFAOYSA-N 0.000 claims description 3
- MPNCLXBLPSQJMJ-UHFFFAOYSA-N methyl 3-benzyl-5-(benzylsulfanylmethyl)-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(CC2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 MPNCLXBLPSQJMJ-UHFFFAOYSA-N 0.000 claims description 3
- RGCUFTHUTSCGGF-UHFFFAOYSA-N methyl 3-benzyl-5-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(CCCC)(C(=O)OC)N=CN1CC1=CC=CC=C1 RGCUFTHUTSCGGF-UHFFFAOYSA-N 0.000 claims description 3
- UIYHYZSTJMJECZ-UHFFFAOYSA-N methyl 3-butyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CC(C)C)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 UIYHYZSTJMJECZ-UHFFFAOYSA-N 0.000 claims description 3
- VNVIXYWKQXGNFQ-UHFFFAOYSA-N methyl 3-butyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 VNVIXYWKQXGNFQ-UHFFFAOYSA-N 0.000 claims description 3
- REZARQLAHUEAOG-UHFFFAOYSA-N methyl 3-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CC(C)C)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 REZARQLAHUEAOG-UHFFFAOYSA-N 0.000 claims description 3
- ALOWJZPJDRSSTI-UHFFFAOYSA-N methyl 3-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 ALOWJZPJDRSSTI-UHFFFAOYSA-N 0.000 claims description 3
- JNASVVSNXIRSGH-UHFFFAOYSA-N methyl 3-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CSC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 JNASVVSNXIRSGH-UHFFFAOYSA-N 0.000 claims description 3
- ZBXMJJGPSGFDFQ-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CC(C)C)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 ZBXMJJGPSGFDFQ-UHFFFAOYSA-N 0.000 claims description 3
- AJADKPRMVOXCKO-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 AJADKPRMVOXCKO-UHFFFAOYSA-N 0.000 claims description 3
- UKRNLSDIOFQGQP-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 UKRNLSDIOFQGQP-UHFFFAOYSA-N 0.000 claims description 3
- VTCOBRHXWIBSFZ-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-[(4-chlorophenyl)methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1N(CCCC)C=NC1(C(=O)OC)CC1=CC=C(Cl)C=C1 VTCOBRHXWIBSFZ-UHFFFAOYSA-N 0.000 claims description 3
- SBTIJPLBBCHHRC-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(CCC=2C=CC=CC=2)N(C)C)CC1 SBTIJPLBBCHHRC-UHFFFAOYSA-N 0.000 claims description 3
- RDKJWOIQLZCMIU-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 RDKJWOIQLZCMIU-UHFFFAOYSA-N 0.000 claims description 3
- HHCOWMRXOBBYEI-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 HHCOWMRXOBBYEI-UHFFFAOYSA-N 0.000 claims description 3
- PBAAOJZERQIIBB-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 PBAAOJZERQIIBB-UHFFFAOYSA-N 0.000 claims description 3
- AJUOYZJWHWRCCU-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(C)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 AJUOYZJWHWRCCU-UHFFFAOYSA-N 0.000 claims description 3
- LLFKSPSUUKWVTI-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 LLFKSPSUUKWVTI-UHFFFAOYSA-N 0.000 claims description 3
- SCJYTXWDTANZHP-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 SCJYTXWDTANZHP-UHFFFAOYSA-N 0.000 claims description 3
- JKALKYGKBNRTHA-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 JKALKYGKBNRTHA-UHFFFAOYSA-N 0.000 claims description 3
- QFEYWLJWQHGTAH-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CC(C)C)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 QFEYWLJWQHGTAH-UHFFFAOYSA-N 0.000 claims description 3
- NUDGQZDSDCRMDJ-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CSC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)CCC1=CC=CC=C1 NUDGQZDSDCRMDJ-UHFFFAOYSA-N 0.000 claims description 3
- AYGNULSLFTYDIP-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(C)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)CCC1=CC=CC=C1 AYGNULSLFTYDIP-UHFFFAOYSA-N 0.000 claims description 3
- WNWWSUOCXNXRAQ-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)CCC1=CC=CC=C1 WNWWSUOCXNXRAQ-UHFFFAOYSA-N 0.000 claims description 3
- XGSYPCLYMGCBFG-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CSCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 XGSYPCLYMGCBFG-UHFFFAOYSA-N 0.000 claims description 3
- NGCDMEKTROWHHE-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 NGCDMEKTROWHHE-UHFFFAOYSA-N 0.000 claims description 3
- OUYNSHAMKRABSI-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CSC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 OUYNSHAMKRABSI-UHFFFAOYSA-N 0.000 claims description 3
- YNBNWAIGBFERQF-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(C)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 YNBNWAIGBFERQF-UHFFFAOYSA-N 0.000 claims description 3
- IBSXYVMWVYBDAS-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 IBSXYVMWVYBDAS-UHFFFAOYSA-N 0.000 claims description 3
- RTXHASOGARYSJN-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CSCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 RTXHASOGARYSJN-UHFFFAOYSA-N 0.000 claims description 3
- VHKBTODLZLQWCR-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 VHKBTODLZLQWCR-UHFFFAOYSA-N 0.000 claims description 3
- IAZCLGMPQUOEOY-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CSC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 IAZCLGMPQUOEOY-UHFFFAOYSA-N 0.000 claims description 3
- SOMPOOCLHYJBGV-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(C)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 SOMPOOCLHYJBGV-UHFFFAOYSA-N 0.000 claims description 3
- ZVRLAGYLHFCASN-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 ZVRLAGYLHFCASN-UHFFFAOYSA-N 0.000 claims description 3
- FOWMRXMAENPXIX-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-cyclohexyl-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CC(C)C)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 FOWMRXMAENPXIX-UHFFFAOYSA-N 0.000 claims description 3
- UQPUMJIREWXFSH-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-cyclohexyl-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 UQPUMJIREWXFSH-UHFFFAOYSA-N 0.000 claims description 3
- GCDPODRUDPUGEY-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(2-methylpropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1C(C(=O)OC)(CC(C)C)N=CN1C(C)C1=CC=CC=C1 GCDPODRUDPUGEY-UHFFFAOYSA-N 0.000 claims description 3
- DAUUJEAPOABNAY-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(2-methylpropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CC(C)C)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 DAUUJEAPOABNAY-UHFFFAOYSA-N 0.000 claims description 3
- CMRAJPYCLCBWRR-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 CMRAJPYCLCBWRR-UHFFFAOYSA-N 0.000 claims description 3
- VMWKTXSJEUCPKU-UHFFFAOYSA-N methyl 4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(C(=O)OC)(CC(C)C)N=CN1C(C)C1=CC=CC=C1 VMWKTXSJEUCPKU-UHFFFAOYSA-N 0.000 claims description 3
- HLYFOJRRGFMHKA-UHFFFAOYSA-N methyl 4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CC(C)C)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 HLYFOJRRGFMHKA-UHFFFAOYSA-N 0.000 claims description 3
- VCQIDKQWKIGUPE-UHFFFAOYSA-N methyl 4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 VCQIDKQWKIGUPE-UHFFFAOYSA-N 0.000 claims description 3
- LXKMRYDOALSBQK-UHFFFAOYSA-N methyl 4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(methylsulfanylmethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CSC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 LXKMRYDOALSBQK-UHFFFAOYSA-N 0.000 claims description 3
- ANVCXFPGVBXCOW-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CC(C)C)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 ANVCXFPGVBXCOW-UHFFFAOYSA-N 0.000 claims description 3
- UOCLNASTGKMBGT-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 UOCLNASTGKMBGT-UHFFFAOYSA-N 0.000 claims description 3
- VBERTXPENGLIEG-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(2-methylpropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(C(=O)OC)(CC(C)C)N=CN1C(C)C1=CC=CC=C1 VBERTXPENGLIEG-UHFFFAOYSA-N 0.000 claims description 3
- RFTDGMSDPLSJSQ-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(2-methylpropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CC(C)C)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 RFTDGMSDPLSJSQ-UHFFFAOYSA-N 0.000 claims description 3
- BDTVIRQRXDRHGF-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 BDTVIRQRXDRHGF-UHFFFAOYSA-N 0.000 claims description 3
- NFSKAEQBOYBCAK-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 NFSKAEQBOYBCAK-UHFFFAOYSA-N 0.000 claims description 3
- ZWPYOPROTVGVBN-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 ZWPYOPROTVGVBN-UHFFFAOYSA-N 0.000 claims description 3
- ISCXJARTILLMPP-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-[(4-chlorophenyl)methyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CC1=CC=C(Cl)C=C1 ISCXJARTILLMPP-UHFFFAOYSA-N 0.000 claims description 3
- DUDXSPVEEAMNEB-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-[(4-chlorophenyl)methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1N(CCC)C=NC1(C(=O)OC)CC1=CC=C(Cl)C=C1 DUDXSPVEEAMNEB-UHFFFAOYSA-N 0.000 claims description 3
- XLDWAYVSNDCSBW-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-3,5-dipropyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(CCC=2C=CC=CC=2)N(C)C)CC1 XLDWAYVSNDCSBW-UHFFFAOYSA-N 0.000 claims description 3
- JVQNSVNIQSDZQL-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-3-(1-phenylethyl)-5-propyl-4H-imidazole-5-carboxylate Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(CCC1=CC=CC=C1)N(C)C)C(C)C1=CC=CC=C1)CCC JVQNSVNIQSDZQL-UHFFFAOYSA-N 0.000 claims description 3
- JNWXAISXZFYSPY-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-methyl-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(CCC1=CC=CC=C1)N(C)C)C(C)C1=CC=CC=C1)C JNWXAISXZFYSPY-UHFFFAOYSA-N 0.000 claims description 3
- WLHLSMGXPCYYPU-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-3,5-dipropyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 WLHLSMGXPCYYPU-UHFFFAOYSA-N 0.000 claims description 3
- OXHFCRDSQJVWCH-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(C(=O)OC)(CCSC)N=CN1C(C)C1=CC=CC=C1 OXHFCRDSQJVWCH-UHFFFAOYSA-N 0.000 claims description 3
- IWGGCJZBMXBIDZ-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 IWGGCJZBMXBIDZ-UHFFFAOYSA-N 0.000 claims description 3
- SQUOVQSUDQKHKP-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 SQUOVQSUDQKHKP-UHFFFAOYSA-N 0.000 claims description 3
- ZCGSVAGZEPPMSS-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 ZCGSVAGZEPPMSS-UHFFFAOYSA-N 0.000 claims description 3
- XYSWUMKLRGUTCG-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(C)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 XYSWUMKLRGUTCG-UHFFFAOYSA-N 0.000 claims description 3
- DUEMRIDOKVCHAO-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-3,5-dipropyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 DUEMRIDOKVCHAO-UHFFFAOYSA-N 0.000 claims description 3
- KYOZQSKUJRFGOU-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(C(=O)OC)(CCSC)N=CN1C(C)C1=CC=CC=C1 KYOZQSKUJRFGOU-UHFFFAOYSA-N 0.000 claims description 3
- NLHQNESOJZRKOU-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 NLHQNESOJZRKOU-UHFFFAOYSA-N 0.000 claims description 3
- ASUOJGUWRMGALT-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 ASUOJGUWRMGALT-UHFFFAOYSA-N 0.000 claims description 3
- GRSHKVALSFDMQZ-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 GRSHKVALSFDMQZ-UHFFFAOYSA-N 0.000 claims description 3
- FFOOAAURSHVRMP-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 FFOOAAURSHVRMP-UHFFFAOYSA-N 0.000 claims description 3
- AVXBEDJIZLNNCL-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 AVXBEDJIZLNNCL-UHFFFAOYSA-N 0.000 claims description 3
- HYYPVXOREJPWCK-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 HYYPVXOREJPWCK-UHFFFAOYSA-N 0.000 claims description 3
- LNSOHNWWBRUVKN-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(CCC=2C=CC=CC=2)N(C)C)CCC1CC1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 LNSOHNWWBRUVKN-UHFFFAOYSA-N 0.000 claims description 3
- BKSFAMIJYPYVFD-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 BKSFAMIJYPYVFD-UHFFFAOYSA-N 0.000 claims description 3
- VNSLSUKERKFYLK-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-cyclohexyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(C2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 VNSLSUKERKFYLK-UHFFFAOYSA-N 0.000 claims description 3
- PYSFUFAZWFPFAX-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(CCC=2C=CC=CC=2)N(C)C)C1(C(=O)OC)CSCC1=CC=CC=C1 PYSFUFAZWFPFAX-UHFFFAOYSA-N 0.000 claims description 3
- IWKWOZDLMDYKQR-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 IWKWOZDLMDYKQR-UHFFFAOYSA-N 0.000 claims description 3
- BMSRTONGNNEHSI-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(C2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 BMSRTONGNNEHSI-UHFFFAOYSA-N 0.000 claims description 3
- CXICYXNSHPYDBW-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1N(CCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 CXICYXNSHPYDBW-UHFFFAOYSA-N 0.000 claims description 3
- CXGSCIVCHWYZCK-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1N(CCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 CXGSCIVCHWYZCK-UHFFFAOYSA-N 0.000 claims description 3
- IQFJDUNSHNDMPA-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 IQFJDUNSHNDMPA-UHFFFAOYSA-N 0.000 claims description 3
- VGECIDUREMTGJU-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1N(CCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 VGECIDUREMTGJU-UHFFFAOYSA-N 0.000 claims description 3
- YZRLOXNTLZUMIM-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1N(CCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 YZRLOXNTLZUMIM-UHFFFAOYSA-N 0.000 claims description 3
- SCVGIOKQZFKPOH-UHFFFAOYSA-N methyl 5-[(4-chlorophenyl)methyl]-3-cyclohexyl-4-[[4-[dimethylamino(thiophen-2-yl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(N(C)C)C=2SC=CC=2)C1(C(=O)OC)CC1=CC=C(Cl)C=C1 SCVGIOKQZFKPOH-UHFFFAOYSA-N 0.000 claims description 3
- FVASXSXRJLPEAX-UHFFFAOYSA-N methyl 5-butan-2-yl-3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(C(C)CC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 FVASXSXRJLPEAX-UHFFFAOYSA-N 0.000 claims description 3
- YQSXCVHDRMLYEZ-UHFFFAOYSA-N methyl 5-butan-2-yl-3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(C(C)CC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 YQSXCVHDRMLYEZ-UHFFFAOYSA-N 0.000 claims description 3
- UOBANTQSQBAULK-UHFFFAOYSA-N methyl 5-butan-2-yl-3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCC(C)C1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 UOBANTQSQBAULK-UHFFFAOYSA-N 0.000 claims description 3
- PMIRAVXKFWDXKT-UHFFFAOYSA-N methyl 5-butan-2-yl-3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCC(C)C1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 PMIRAVXKFWDXKT-UHFFFAOYSA-N 0.000 claims description 3
- WLJZCQLTOQQPED-UHFFFAOYSA-N methyl 5-butan-2-yl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(C(C)CC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 WLJZCQLTOQQPED-UHFFFAOYSA-N 0.000 claims description 3
- DERPEMCHDGVREK-UHFFFAOYSA-N methyl 5-butyl-3-cyclohexyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 DERPEMCHDGVREK-UHFFFAOYSA-N 0.000 claims description 3
- YIWSNSGYITWXGY-UHFFFAOYSA-N methyl 5-butyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 YIWSNSGYITWXGY-UHFFFAOYSA-N 0.000 claims description 3
- YQKNRFFVZLGAAC-UHFFFAOYSA-N methyl 5-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(CCC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 YQKNRFFVZLGAAC-UHFFFAOYSA-N 0.000 claims description 3
- IOZOWVJZVPDWQS-UHFFFAOYSA-N methyl 5-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 IOZOWVJZVPDWQS-UHFFFAOYSA-N 0.000 claims description 3
- VGRKVGNCRJBHDN-UHFFFAOYSA-N methyl 5-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(CCC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 VGRKVGNCRJBHDN-UHFFFAOYSA-N 0.000 claims description 3
- 230000008450 motivation Effects 0.000 claims description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- KBDOWHOIOUBRKJ-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 KBDOWHOIOUBRKJ-UHFFFAOYSA-N 0.000 claims description 2
- XKUMVTDDJYRYRX-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 XKUMVTDDJYRYRX-UHFFFAOYSA-N 0.000 claims description 2
- NWPOHFOHYBJQKQ-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 NWPOHFOHYBJQKQ-UHFFFAOYSA-N 0.000 claims description 2
- 230000006698 induction Effects 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 18
- 150000001875 compounds Chemical class 0.000 abstract description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 90
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 87
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 57
- 239000000243 solution Substances 0.000 description 51
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 40
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- 238000001816 cooling Methods 0.000 description 32
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- 239000000284 extract Substances 0.000 description 24
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 23
- 229910052786 argon Inorganic materials 0.000 description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 19
- 239000008346 aqueous phase Substances 0.000 description 18
- 239000011734 sodium Substances 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 239000012043 crude product Substances 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- SJFNDMHZXCUXSA-UHFFFAOYSA-M methoxymethyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(COC)C1=CC=CC=C1 SJFNDMHZXCUXSA-UHFFFAOYSA-M 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 14
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- 238000003818 flash chromatography Methods 0.000 description 11
- 150000002576 ketones Chemical class 0.000 description 11
- 239000012074 organic phase Substances 0.000 description 9
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000005457 ice water Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000010626 work up procedure Methods 0.000 description 8
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 125000005219 aminonitrile group Chemical group 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 0 *C(C(CC1)CCC1=O)N(*)* Chemical compound *C(C(CC1)CCC1=O)N(*)* 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 125000000753 cycloalkyl group Chemical group 0.000 description 5
- 235000019439 ethyl acetate Nutrition 0.000 description 5
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- 101001122476 Homo sapiens Mu-type opioid receptor Proteins 0.000 description 4
- 102100028647 Mu-type opioid receptor Human genes 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- UXXWGBLTOSRBAY-UHFFFAOYSA-N ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate Chemical compound C1CC(C(=O)OCC)CCC21OCCO2 UXXWGBLTOSRBAY-UHFFFAOYSA-N 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 125000002541 furyl group Chemical group 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- HFBULKBCEFQYCJ-UHFFFAOYSA-N 1,4-dioxaspiro[4.5]decane-8-carbaldehyde Chemical compound C1CC(C=O)CCC21OCCO2 HFBULKBCEFQYCJ-UHFFFAOYSA-N 0.000 description 3
- OTILTWNSTXKYQN-UHFFFAOYSA-N 4-[(dimethylamino)methyl]cyclohexane-1-carbaldehyde Chemical compound CN(C)CC1CCC(C=O)CC1 OTILTWNSTXKYQN-UHFFFAOYSA-N 0.000 description 3
- 239000007818 Grignard reagent Substances 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000004795 grignard reagents Chemical class 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 125000001041 indolyl group Chemical group 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LFFZWEFAJJDMKZ-UHFFFAOYSA-N 1-(1,4-dioxaspiro[4.5]decan-8-yl)-n,n-dimethylmethanamine Chemical compound C1CC(CN(C)C)CCC21OCCO2 LFFZWEFAJJDMKZ-UHFFFAOYSA-N 0.000 description 2
- UVBHJMKYLQOHTO-UHFFFAOYSA-N 2-(dimethylamino)-2-(1,4-dioxaspiro[4.5]decan-8-yl)acetonitrile Chemical compound C1CC(C(C#N)N(C)C)CCC21OCCO2 UVBHJMKYLQOHTO-UHFFFAOYSA-N 0.000 description 2
- OMYSWSQWLSIWPW-UHFFFAOYSA-N 2-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]acetaldehyde Chemical compound C=1C=C(Cl)C=CC=1C(N(C)C)C1CCC(CC=O)CC1 OMYSWSQWLSIWPW-UHFFFAOYSA-N 0.000 description 2
- GSMUVUIZLQIWSJ-UHFFFAOYSA-N 2-[4-[(dimethylamino)methyl]cyclohexyl]acetaldehyde Chemical compound CN(C)CC1CCC(CC=O)CC1 GSMUVUIZLQIWSJ-UHFFFAOYSA-N 0.000 description 2
- BEFVDKBDNSOQFU-UHFFFAOYSA-N 2-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]acetaldehyde Chemical compound C=1C=CC(F)=CC=1C(N(C)C)C1CCC(CC=O)CC1 BEFVDKBDNSOQFU-UHFFFAOYSA-N 0.000 description 2
- UJUIUNYYEYSDSS-UHFFFAOYSA-N 2-[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]acetaldehyde Chemical compound C=1C=C(F)C=CC=1C(N(C)C)C1CCC(CC=O)CC1 UJUIUNYYEYSDSS-UHFFFAOYSA-N 0.000 description 2
- HWLIOUQUSWVEAB-UHFFFAOYSA-N 4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=C(Cl)C=CC=1C(N(C)C)C1CCC(C=O)CC1 HWLIOUQUSWVEAB-UHFFFAOYSA-N 0.000 description 2
- CXDCQPPTWNFDAP-UHFFFAOYSA-N 4-[(dimethylamino)methyl]cyclohexan-1-one Chemical compound CN(C)CC1CCC(=O)CC1 CXDCQPPTWNFDAP-UHFFFAOYSA-N 0.000 description 2
- SZZQUNGEKHJLSO-UHFFFAOYSA-N 4-[1-(dimethylamino)-3-phenylpropyl]cyclohexane-1-carbaldehyde Chemical compound C1CC(C=O)CCC1C(N(C)C)CCC1=CC=CC=C1 SZZQUNGEKHJLSO-UHFFFAOYSA-N 0.000 description 2
- TYXPQTLYRLSITM-UHFFFAOYSA-N 4-[dimethylamino(thiophen-2-yl)methyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=CSC=1C(N(C)C)C1CCC(C=O)CC1 TYXPQTLYRLSITM-UHFFFAOYSA-N 0.000 description 2
- QXNODLYWYULBDT-UHFFFAOYSA-N 4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=CC(F)=CC=1C(N(C)C)C1CCC(C=O)CC1 QXNODLYWYULBDT-UHFFFAOYSA-N 0.000 description 2
- YTPAMINNYYCHGG-UHFFFAOYSA-N 4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=C(F)C=CC=1C(N(C)C)C1CCC(C=O)CC1 YTPAMINNYYCHGG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000020401 Depressive disease Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- ZXYAWONOWHSQRU-UHFFFAOYSA-N ethyl 4-oxocyclohexanecarboxylate Chemical compound CCOC(=O)C1CCC(=O)CC1 ZXYAWONOWHSQRU-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002527 isonitriles Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 102000051367 mu Opioid Receptors Human genes 0.000 description 2
- 229960004127 naloxone Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002287 radioligand Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 108020001612 μ-opioid receptors Proteins 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- XZZNXMLSUXWNPQ-UHFFFAOYSA-N 1-(1,4-dioxaspiro[4.5]decan-8-yl)-1-(3-fluorophenyl)-n,n-dimethylmethanamine Chemical compound C=1C=CC(F)=CC=1C(N(C)C)C(CC1)CCC21OCCO2 XZZNXMLSUXWNPQ-UHFFFAOYSA-N 0.000 description 1
- XQAYGXXXHULGHN-UHFFFAOYSA-N 1-(1,4-dioxaspiro[4.5]decan-8-yl)-1-(4-fluorophenyl)-n,n-dimethylmethanamine Chemical compound C=1C=C(F)C=CC=1C(N(C)C)C(CC1)CCC21OCCO2 XQAYGXXXHULGHN-UHFFFAOYSA-N 0.000 description 1
- TVLNOHUXNVXJGB-UHFFFAOYSA-N 1-(1,4-dioxaspiro[4.5]decan-8-yl)-n,n-dimethyl-1-thiophen-2-ylmethanamine Chemical compound C=1C=CSC=1C(N(C)C)C(CC1)CCC21OCCO2 TVLNOHUXNVXJGB-UHFFFAOYSA-N 0.000 description 1
- SGAKOIAUKSQAPH-UHFFFAOYSA-N 1-(1,4-dioxaspiro[4.5]decan-8-yl)-n,n-dimethyl-3-phenylpropan-1-amine Chemical compound C1CC2(OCCO2)CCC1C(N(C)C)CCC1=CC=CC=C1 SGAKOIAUKSQAPH-UHFFFAOYSA-N 0.000 description 1
- XIVUJJFPLKQYIA-UHFFFAOYSA-N 1-(4-chlorophenyl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-n,n-dimethylmethanamine Chemical compound C=1C=C(Cl)C=CC=1C(N(C)C)C(CC1)CCC21OCCO2 XIVUJJFPLKQYIA-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- FFFIRKXTFQCCKJ-UHFFFAOYSA-N 2,4,6-trimethylbenzoic acid Chemical compound CC1=CC(C)=C(C(O)=O)C(C)=C1 FFFIRKXTFQCCKJ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- VIKBNMWOLLIQPG-UHFFFAOYSA-N 2-methyldecanedioic acid Chemical compound OC(=O)C(C)CCCCCCCC(O)=O VIKBNMWOLLIQPG-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- AJHPGXZOIAYYDW-UHFFFAOYSA-N 3-(2-cyanophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(C(O)=O)CC1=CC=CC=C1C#N AJHPGXZOIAYYDW-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- MLPKZGJNEGVESO-UHFFFAOYSA-N 4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexan-1-one Chemical compound C=1C=C(Cl)C=CC=1C(N(C)C)C1CCC(=O)CC1 MLPKZGJNEGVESO-UHFFFAOYSA-N 0.000 description 1
- SXJDBONDCAPKQZ-UHFFFAOYSA-N 4-[1-(dimethylamino)-3-phenylpropyl]cyclohexan-1-one Chemical compound C1CC(=O)CCC1C(N(C)C)CCC1=CC=CC=C1 SXJDBONDCAPKQZ-UHFFFAOYSA-N 0.000 description 1
- HOYBGBLFHZPEGW-UHFFFAOYSA-N 4-[dimethylamino(thiophen-2-yl)methyl]cyclohexan-1-one Chemical compound C=1C=CSC=1C(N(C)C)C1CCC(=O)CC1 HOYBGBLFHZPEGW-UHFFFAOYSA-N 0.000 description 1
- JPVZNSBFRLDNEK-UHFFFAOYSA-N 4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexan-1-one Chemical compound C=1C=CC(F)=CC=1C(N(C)C)C1CCC(=O)CC1 JPVZNSBFRLDNEK-UHFFFAOYSA-N 0.000 description 1
- KLFLJXZRAXPMOU-UHFFFAOYSA-N 4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexan-1-one Chemical compound C=1C=C(F)C=CC=1C(N(C)C)C1CCC(=O)CC1 KLFLJXZRAXPMOU-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- 125000006519 CCH3 Chemical group 0.000 description 1
- CDEMHJCJMMOFMB-UHFFFAOYSA-M ClC1=CC=C([Mg]Br)C=C1 Chemical compound ClC1=CC=C([Mg]Br)C=C1 CDEMHJCJMMOFMB-UHFFFAOYSA-M 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010038678 Respiratory depression Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 108010046516 Wheat Germ Agglutinins Proteins 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical group 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000005469 ethylenyl group Chemical group 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000013284 inhibition of norepinephrine uptake Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- HTJPDOPKPWUNBX-UHFFFAOYSA-M magnesium;2h-thiophen-2-ide;bromide Chemical compound [Mg+2].[Br-].C=1C=[C-]SC=1 HTJPDOPKPWUNBX-UHFFFAOYSA-M 0.000 description 1
- OUTILEHLSPAZIN-UHFFFAOYSA-M magnesium;ethylbenzene;chloride Chemical compound [Mg+2].[Cl-].[CH2-]CC1=CC=CC=C1 OUTILEHLSPAZIN-UHFFFAOYSA-M 0.000 description 1
- BRKADVNLTRCLOW-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=[C-]C=C1 BRKADVNLTRCLOW-UHFFFAOYSA-M 0.000 description 1
- DTKMKZYEOXZPQZ-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=C[C-]=C1 DTKMKZYEOXZPQZ-UHFFFAOYSA-M 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- OPHMCBWUQRAKEO-UHFFFAOYSA-N methyl 2-formamido-3-phenylpropanoate Chemical compound COC(=O)C(NC=O)CC1=CC=CC=C1 OPHMCBWUQRAKEO-UHFFFAOYSA-N 0.000 description 1
- CEPQFHINGYLWCQ-UHFFFAOYSA-N methyl 2-isocyano-3-phenylpropanoate Chemical compound COC(=O)C([N+]#[C-])CC1=CC=CC=C1 CEPQFHINGYLWCQ-UHFFFAOYSA-N 0.000 description 1
- VTWRORWDADHKFE-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1CC1=CC=CC=C1 VTWRORWDADHKFE-UHFFFAOYSA-N 0.000 description 1
- LPGVYFOFYXQYHY-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 LPGVYFOFYXQYHY-UHFFFAOYSA-N 0.000 description 1
- QPYFAEQAZRVDIK-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 QPYFAEQAZRVDIK-UHFFFAOYSA-N 0.000 description 1
- SZRFJRYDBNOOBN-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CSC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 SZRFJRYDBNOOBN-UHFFFAOYSA-N 0.000 description 1
- WUMLPDPFFWWRBZ-UHFFFAOYSA-N methyl 5-butan-2-yl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound CCC(C)C1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 WUMLPDPFFWWRBZ-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical compound C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 230000000697 serotonin reuptake Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005061430A DE102005061430A1 (de) | 2005-12-22 | 2005-12-22 | Substituierte Imidazolin-Derivate |
| PCT/EP2006/012221 WO2007079927A1 (de) | 2005-12-22 | 2006-12-19 | Substituierte imidazolin-derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009523124A true JP2009523124A (ja) | 2009-06-18 |
| JP2009523124A5 JP2009523124A5 (enExample) | 2012-12-13 |
Family
ID=37946192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546224A Ceased JP2009523124A (ja) | 2005-12-22 | 2006-12-19 | 置換されたイミダゾリン誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7728028B2 (enExample) |
| EP (1) | EP1963278B1 (enExample) |
| JP (1) | JP2009523124A (enExample) |
| CN (1) | CN101384557A (enExample) |
| AT (1) | ATE449075T1 (enExample) |
| AU (1) | AU2006334743B2 (enExample) |
| CA (1) | CA2633918A1 (enExample) |
| CY (1) | CY1110465T1 (enExample) |
| DE (2) | DE102005061430A1 (enExample) |
| DK (1) | DK1963278T3 (enExample) |
| ES (1) | ES2336833T3 (enExample) |
| IL (1) | IL192268A0 (enExample) |
| PL (1) | PL1963278T3 (enExample) |
| PT (1) | PT1963278E (enExample) |
| RU (1) | RU2427571C2 (enExample) |
| SI (1) | SI1963278T1 (enExample) |
| WO (1) | WO2007079927A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2257526T3 (pl) | 2008-03-27 | 2012-05-31 | Gruenenthal Gmbh | Pochodne spiro (5.5) undekanu |
| US8357705B2 (en) | 2008-03-27 | 2013-01-22 | Gruenenthal Gmbh | Substituted cyclohexyldiamines |
| ES2694103T3 (es) | 2008-03-27 | 2018-12-18 | Grünenthal GmbH | Derivados de 4-aminociclohexano sustituidos |
| CL2009000731A1 (es) | 2008-03-27 | 2009-05-15 | Gruenenthal Gmbh | Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea. |
| JP5599774B2 (ja) | 2008-03-27 | 2014-10-01 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ヒドロキシメチルシクロヘキシルアミン類 |
| HUE026184T2 (en) | 2008-03-27 | 2016-05-30 | Gruenenthal Gmbh | (Hetero-) aryl-cyclohexane derivatives |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001513556A (ja) * | 1997-08-28 | 2001-09-04 | イーライ・リリー・アンド・カンパニー | ニューロパシー痛の治療方法 |
| JP2001513532A (ja) * | 1997-08-28 | 2001-09-04 | イーライ・リリー・アンド・カンパニー | 痛みを処置するための方法 |
| JP2003519210A (ja) * | 2000-01-05 | 2003-06-17 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 置換アミノメチル−フェニル−シクロヘキサン誘導体 |
| WO2004066996A1 (en) * | 2003-01-17 | 2004-08-12 | Michigan State University | NF-kB INHIBITORS AND USES THEREOF |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7183276B2 (en) * | 2002-02-28 | 2007-02-27 | Takeda Pharmaceutical Company Limited | Azole compounds |
| US6878735B2 (en) * | 2002-05-31 | 2005-04-12 | Board Of Trustees Of Michigan State University | Multi-substituted imidazolines and method of use thereof |
| DE102005061429A1 (de) * | 2005-12-22 | 2007-06-28 | Grünenthal GmbH | Substituierte Oxazol-Derivate |
-
2005
- 2005-12-22 DE DE102005061430A patent/DE102005061430A1/de not_active Withdrawn
-
2006
- 2006-12-19 AT AT06841028T patent/ATE449075T1/de active
- 2006-12-19 PT PT06841028T patent/PT1963278E/pt unknown
- 2006-12-19 JP JP2008546224A patent/JP2009523124A/ja not_active Ceased
- 2006-12-19 RU RU2008129377/04A patent/RU2427571C2/ru not_active IP Right Cessation
- 2006-12-19 DE DE502006005426T patent/DE502006005426D1/de active Active
- 2006-12-19 CN CNA2006800532577A patent/CN101384557A/zh active Pending
- 2006-12-19 SI SI200630546T patent/SI1963278T1/sl unknown
- 2006-12-19 ES ES06841028T patent/ES2336833T3/es active Active
- 2006-12-19 WO PCT/EP2006/012221 patent/WO2007079927A1/de not_active Ceased
- 2006-12-19 EP EP06841028A patent/EP1963278B1/de not_active Not-in-force
- 2006-12-19 DK DK06841028.1T patent/DK1963278T3/da active
- 2006-12-19 AU AU2006334743A patent/AU2006334743B2/en not_active Ceased
- 2006-12-19 CA CA002633918A patent/CA2633918A1/en not_active Abandoned
- 2006-12-19 PL PL06841028T patent/PL1963278T3/pl unknown
-
2008
- 2008-06-18 IL IL192268A patent/IL192268A0/en unknown
- 2008-06-20 US US12/143,566 patent/US7728028B2/en not_active Expired - Fee Related
-
2010
- 2010-02-02 CY CY20101100093T patent/CY1110465T1/el unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001513556A (ja) * | 1997-08-28 | 2001-09-04 | イーライ・リリー・アンド・カンパニー | ニューロパシー痛の治療方法 |
| JP2001513532A (ja) * | 1997-08-28 | 2001-09-04 | イーライ・リリー・アンド・カンパニー | 痛みを処置するための方法 |
| JP2003519210A (ja) * | 2000-01-05 | 2003-06-17 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 置換アミノメチル−フェニル−シクロヘキサン誘導体 |
| WO2004066996A1 (en) * | 2003-01-17 | 2004-08-12 | Michigan State University | NF-kB INHIBITORS AND USES THEREOF |
Also Published As
| Publication number | Publication date |
|---|---|
| PT1963278E (pt) | 2009-12-16 |
| SI1963278T1 (sl) | 2010-03-31 |
| DE502006005426D1 (de) | 2009-12-31 |
| EP1963278B1 (de) | 2009-11-18 |
| US20090048323A1 (en) | 2009-02-19 |
| ATE449075T1 (de) | 2009-12-15 |
| AU2006334743A1 (en) | 2007-07-19 |
| RU2427571C2 (ru) | 2011-08-27 |
| CN101384557A (zh) | 2009-03-11 |
| US7728028B2 (en) | 2010-06-01 |
| CA2633918A1 (en) | 2007-07-19 |
| WO2007079927A1 (de) | 2007-07-19 |
| CY1110465T1 (el) | 2015-04-29 |
| AU2006334743B2 (en) | 2011-07-07 |
| HK1122019A1 (zh) | 2009-05-08 |
| EP1963278A1 (de) | 2008-09-03 |
| IL192268A0 (en) | 2008-12-29 |
| DE102005061430A1 (de) | 2007-07-05 |
| DK1963278T3 (da) | 2010-03-29 |
| PL1963278T3 (pl) | 2010-04-30 |
| RU2008129377A (ru) | 2010-03-27 |
| ES2336833T3 (es) | 2010-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4791374B2 (ja) | スピロ環状シクロヘキサン誘導体 | |
| US8124788B2 (en) | Spirocyclic cyclohexane compounds with analgesic activity | |
| US5352788A (en) | N-substituted heterocyclic derivatives | |
| RU2525236C2 (ru) | Замещенные производные 4-аминоциклогексана | |
| JP5599774B2 (ja) | ヒドロキシメチルシクロヘキシルアミン類 | |
| US7589113B2 (en) | Substituted oxadiazole compounds and their use as opioid receptor ligands | |
| JP4982357B2 (ja) | ヘテロアリール−置換されたシクロヘキシル−1,4−ジアミン誘導体 | |
| IL103116A (en) | History of N-transformed heterocyclics, pharmaceutical preparations containing certain compounds and their preparation | |
| US7728028B2 (en) | Substituted imidazoline compounds | |
| PT1751093E (pt) | Derivados de ácido ciclo-hexilacético substituídos | |
| AU691057B2 (en) | 3-alkoxybenzylpiperidine derivatives as melatonergic agents | |
| EA015974B1 (ru) | Производные пирролизина, индолизина и хинолизина, их получение и их применение в терапии | |
| JP4874237B2 (ja) | 置換されたシクロヘキシルカルボン酸誘導体 | |
| JP6216385B2 (ja) | 3,4−二置換オキサゾリジノン誘導体及びカルシウム活性化カリウムチャネルの阻害薬としてのそれらの使用 | |
| JP5037336B2 (ja) | 鎖長が延ばされ、置換されたシクロヘキシル−1,4−ジアミンの酸誘導体 | |
| JP2009520718A (ja) | 鎮痛作用を有する置換されたオキサゾール誘導体 | |
| US6005118A (en) | Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors | |
| AU2002221632B8 (en) | 5-amino-1-pentene-3-ol substituted derivatives | |
| MX2008008067A (en) | Substituted imidazoline derivatives | |
| WO2002014272A1 (en) | (thio)urea derivatives, process for their production and medicines containing the derivatives | |
| AU723180B2 (en) | Novel compound with platelet aggregation inhibitor activity | |
| WO1995029910A1 (fr) | Derive d'imidazolidinedione | |
| HK1122019B (en) | Substituted imidazoline derivatives | |
| GB2413326A (en) | Nefopam analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090820 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20100518 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120717 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121016 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121023 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20121026 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121029 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121211 |
|
| A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20130514 |